ACADIA HOSPITAL
1. Target Overview & Investment Thesis
ACADIA HOSPITAL is a 68-bed safety-net/medicaid heavy in PENOBSCOT, ME with $65.0M in net patient revenue and a -1.4% operating margin. The hospital serves a payer mix of 9.2% Medicare, 33.9% Medicaid, and 56.9% commercial.
Thesis: Turnaround. Our ML models identify $4.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.4% to 5.9% (+736bps).
| Net Revenue HCRIS | $65.0M |
| Current EBITDA COMPUTED | $-938K |
| Operating Margin COMPUTED | -1.4% |
| Occupancy HCRIS | 92.3% |
| Revenue / Bed COMPUTED | $957K |
| Net-to-Gross HCRIS | 49.9% |
| Distress Probability ML | 47.4% |
2. Market Context & Competitive Position
ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -1.4% places it above the state median. Among 14 size-comparable peers (34-136 beds), the median margin is -12.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (34-136), prioritizing same-state peers. 14 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ACADIA HOSPITAL (Target) | ME | 68 | $65.0M | -1.4% |
| MERCY HOSPITAL | ME | 77 | $240.0M | -11.6% |
| MID COAST HOSPITAL | ME | 93 | $213.6M | -14.0% |
| YORK HOSPITAL | ME | 54 | $197.1M | -3.6% |
| ST JOSEPH HOSPITAL | ME | 99 | $176.8M | -9.2% |
| PENOBSCOT BAY MEDICAL CENTER | ME | 81 | $171.6M | -21.7% |
| THE AROOSTOOK MEDICAL CENTER | ME | 34 | $134.8M | -23.5% |
| FRANKLIN MEMORIAL HOSPITAL | ME | 46 | $103.4M | -17.3% |
| MAINE COAST MEMORIAL HOSPITAL | ME | 45 | $98.0M | -5.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $792K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $42K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-938K |
| + RCM Uplift | +$4.8M |
| Pro Forma EBITDA | $3.8M |
| Current Margin | -1.4% |
| Pro Forma Margin | 5.9% |
| WC Released (1x) | $2.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-1.4M | $41.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-1.4M | $45.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.3M | $60.7M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.3M | $65.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-1.6M | $18.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-1.6M | $19.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (33.9%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 14 hospitals with 34-136 beds
- Same-state prioritization (n=15)
- Comp margins: P25=-22.1% / P50=-12.8% / P75=-8.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.